Skip to main content

Month: September 2020

Applied Materials Welcomes Technical Advisory Board

SANTA CLARA, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced it has formed a Growth Technical Advisory Board (GTAB) composed of leading academic and industry luminaries with a diverse set of backgrounds in fields including science, technology, government and education. The GTAB offers Applied unique perspectives on how major industries will evolve as technology becomes increasingly pervasive in the decade ahead.The Applied Materials GTAB members are:Paul Alivisatos: Vice Chancellor and Provost at the University of California, Berkeley and quantum dot pioneerSteve Blank: Adjunct Professor at Stanford University and Innovation Fellow at Columbia University, lean startup pioneer and author of National Science Foundation I-Corps curriculumSteven Chu: Professor at Stanford University, Nobel laureate...

Continue reading

Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 22nd Annual Global Investment Conference

WEST CHESTER, Pa., Sept. 09, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica President and CEO, will present a business overview at the H.C. Wainwright 22nd Annual Global Investment Conference, taking place virtually on Tuesday, September 15, 2020, at 2:00 p.m. ET.A live webcast of the event can be accessed in the Investors/Presentations & Events section of the Verrica website at http://www.verrica.com. The webcast replay will be available shortly after conclusion of the event for 30 days. About Verrica Pharmaceuticals Inc.Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. The...

Continue reading

WPD Pharmaceuticals Engages Worldwide Clinical Trials as CRO for Phase 2 Berubicin Trials

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (“WPD” or the “Company”) (CSE: WBIO) (FSE: 8SV1), a clinical stage pharmaceutical company, is pleased to announce that is has engaged world-renowned Contract Research Organization (“CRO”), Worldwide Clinical Trials (“WCT”) to coordinate and supervise Phase 1 and 2 clinical trials on its Berubicin drug candidate.WCT will provide research services, implementation of start-up activities, organization and development for clinical trials being conducted by WPD in adult and pediatric populations with Glioblastoma, according to international standards of good clinical practice (ICH GCP) and other applicable regulatory requirements. These requirements include safety management, pharmaco-vigilancem and data management. WCT will also support WPD’s application...

Continue reading

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference

YONKERS, N.Y., Sept. 09, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, today announced that Roger J. Pomerantz, M.D., President, Chief Executive Officer and Chairman of ContraFect, will participate in a Fireside Chat at the 2020 Cantor Global Virtual Healthcare Conference on Wednesday, September 16, 2020, at 9:20am ET.A live webcast of the presentation will be available on the Investors & Media section of the Company’s website at www.contrafect.com. The presentation will also be available as an archived webcast for a limited time. About ContraFect:ContraFect is a biotechnology...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Fourth Quarter and Fiscal 2020 Results

VONORE, Tenn., Sept. 09, 2020 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2020 fourth quarter and year ended June 30, 2020.Fourth Quarter Highlights:Ended the year with stronger than anticipated retail demand across all brands and dealer inventories 40 percent to 50 percent lower vs. end of fiscal 2019.Safely resumed all manufacturing operations, but production and sales heavily impacted by COVID-19 shutdowns.Repaid $25.0 million on revolving credit facility and ended the quarter with strong liquidity position.Net sales for the fourth quarter decreased to $51.1 million, down 58.4 percent from $122.8 million in the prior-year period.Net loss was $(2.8) million or $(0.15) per diluted share.Diluted Adjusted Net Loss per share, a non-GAAP measure, was $(0.10) compared...

Continue reading

Aehr Test Systems announces changes to its Board of Directors

FREMONT, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, today announced it has appointed Geoff Scott to its board of directors, effective September 2, 2020.  The Company also announced John Schneider, who has served on the Aehr Test Systems board since 2014, has resigned for personal reasons effective September 2, 2020.  The number of Aehr Test board members remains at six.“Geoff brings a background of both corporate finance and Board level engagement. As an investor in emerging high growth companies, his experience will be a valuable addition as we continue to focus on the many expanding opportunities for the Company.  I would also like to take this opportunity to thank John for more than 5 years of service, support...

Continue reading

Corning Provides Financial Update at Citi 2020 Global Technology Conference

CORNING, NY, Sept. 09, 2020 (GLOBE NEWSWIRE) — Corning Incorporated (NYSE:GLW) Chief Financial Officer Tony Tripeny and Chief Strategy Officer Jeff Evenson will address investors during a fireside chat followed by a question-and-answer session at the Citi 2020 Global Technology Conference Wednesday.A financial update about the company’s expected performance in the third quarter will be provided. Highlights include:Third-quarter sales are expected to grow by a low-teen percentage sequentially. Profitability growth is expected to outpace sales growth as the company’s cost-control efforts enhance operating leverage. The company remains on track for positive free cash flow for the year.Tripeny will tell conference attendees, “I’m pleased to share that the positive momentum seen in July has continued, and we expect third-quarter sequential...

Continue reading

Tauriga Sciences, Inc. Completes the Alternative Package Designs for its Entire Tauri-Gum Product Line

NEW YORK, NY , Sept. 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that it has completed the alternative package designs for its entire Tauri-Gum™ product line. This is an important milestone, as some of the Company’s retail customers (most notably Erewhon Market), require that alternative packaging be made available.  The Company is also confident that, during its ongoing national product launch, the availability of alternative packaging will be helpful.     The Company’s Tauri-Gum™ product...

Continue reading

Anmodning om ophævelse af suspension af samtlige afdelinger i Investeringsforeningen PFA Invest

Investeringsforeningen PFA Invest er igen i stand til at beregne indre værdier, og der anmodes om ophævelse af suspension for nedenstående afdelinger i Investeringsforeningen PFA InvestEventuel henvendelse vedrørende denne meddelelse kan rettes til Stine Bernt Simonsen på sbs@pfa.dk eller på telefon 39 17 60 87.Med venlig hilsenPFA Asset Management A/S  

Continue reading

JSHG Announces C1 JV Property Drill Results

WOODSTOCK, Ontario, Sept. 09, 2020 (GLOBE NEWSWIRE) — Joshua Gold Resources Inc. (OTC: JSHG) an American gold and mineral exploration company headquartered in Canada, home to the three-billion-year old Canadian Shield is pleased to announce results from drill hole J-11-20 that was completed on the C1 JV Property (“Property”) during the month of July 2020.The Property is located approximately 115 km southwest of Timmins, Ontario. The Timmins area is one of the richest goldfields in the world, and over the past century has produced more gold than any mining region in Canada. Today, the city of Timmins, northern Ontario’s third largest, remains one of Canada’s major mining centers.Drill hole number J-11-20, drilled to a depth of 263.00 m with a dip of -60 degrees to undercut the mineralization intersection in drill holes...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.